top of page

USPSTF Reaffirms Its Recommendation Against Screening for Chronic Obstructive Pulmonary Disease

Despite a 2016 recommendation against screening for chronic obstructive pulmonary disease (COPD),the USPSTF recognizes the substantial morbidity and mortality burdens of COPD (particularly in women and minority patients). The Task Force now has revisited this issue to determine if any new evidence would support a change in its 2016 D recommendation (NEJM JW Gen Med May 15 2016 and JAMA2016; 315:1372).

The target population of this recommendation is asymptomatic adults who do not recognize or report respiratory symptoms, such as a chronic cough, sputum production, or difficulty breathing. The recommendation does not apply to patients at especially high risk for COPD, including those with α-1-antitrypsin deficiency or occupational toxin exposures.

Recommendation: The Task Force continues to recommend against screening for COPD (D recommendation).

Learn more about how IHD can help you screen your patients: Testing for Providers.

Thomas L. Schwenk, MD, reviewing Mangione CM et al. JAMA 2022 May 10 Webber EM et al. JAMA 2022 May 10

The U.S. Preventive Services Task Force found no new evidence and continues to focus on reducing harm from tobacco use.

Sponsoring Organization: U.S. Preventive Services Task Force (USPSTF)


bottom of page